Fresh Rounds

Xenagos Bio, Inc. funding

Xenagos Bio, Inc., a biotechnology company based in Philadelphia, PA (founded 2025), filed a Form D with the SEC on May 15, 2026 and reported $2.5M raised.

Amount raised$2.5M
Offering size$2.5M
Filed with the SECMay 15, 2026
First saleApril 30, 2026
IndustryBiotechnology
SecuritiesEquity
LocationPhiladelphia, PA
Founded2025
Entity typeCorporation
Investors so far23
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Pennsylvania